BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 895 filers reported holding BAXTER INTL INC in Q1 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $127,179,221 | -20.4% | 3,369,870 | -3.9% | 0.04% | -15.4% |
Q2 2023 | $159,795,903 | +12.8% | 3,507,375 | +0.4% | 0.05% | +2.0% |
Q1 2023 | $141,703,883 | -19.8% | 3,493,688 | +0.8% | 0.05% | -25.0% |
Q4 2022 | $176,624,032 | -9.5% | 3,465,254 | -4.3% | 0.07% | -10.5% |
Q3 2022 | $195,103,000 | -19.0% | 3,622,400 | -3.5% | 0.08% | -10.6% |
Q2 2022 | $241,003,000 | -27.7% | 3,752,200 | -12.8% | 0.08% | -15.8% |
Q1 2022 | $333,567,000 | -5.4% | 4,301,861 | +4.8% | 0.10% | -5.6% |
Q4 2021 | $352,492,000 | +3.4% | 4,106,389 | -3.1% | 0.11% | -3.6% |
Q3 2021 | $340,758,000 | +3.4% | 4,236,716 | +3.5% | 0.11% | +0.9% |
Q2 2021 | $329,674,000 | +2.4% | 4,095,329 | +7.3% | 0.11% | -8.3% |
Q1 2021 | $322,004,000 | +4.5% | 3,817,914 | -0.6% | 0.12% | -0.8% |
Q4 2020 | $308,218,000 | +0.3% | 3,841,218 | +0.5% | 0.12% | -11.7% |
Q3 2020 | $307,429,000 | -6.5% | 3,822,804 | +0.1% | 0.14% | -13.8% |
Q2 2020 | $328,757,000 | +8.3% | 3,819,353 | +2.1% | 0.16% | -10.7% |
Q1 2020 | $303,692,000 | +1.2% | 3,739,155 | +4.2% | 0.18% | +24.5% |
Q4 2019 | $300,079,000 | -2.3% | 3,588,732 | +2.2% | 0.14% | -11.7% |
Q3 2019 | $307,213,000 | +8.4% | 3,512,688 | +1.5% | 0.16% | +6.6% |
Q2 2019 | $283,415,000 | -0.8% | 3,460,802 | -1.5% | 0.15% | -6.7% |
Q1 2019 | $285,576,000 | +48.4% | 3,512,900 | +20.1% | 0.16% | +9.4% |
Q4 2018 | $192,441,000 | -6.3% | 2,924,443 | +9.8% | 0.15% | +1.4% |
Q3 2018 | $205,427,000 | +4.3% | 2,664,384 | -0.1% | 0.15% | -3.3% |
Q2 2018 | $196,871,000 | +6.5% | 2,666,122 | -6.2% | 0.15% | +7.8% |
Q1 2018 | $184,812,000 | -10.6% | 2,842,472 | -11.1% | 0.14% | -6.0% |
Q4 2017 | $206,799,000 | +0.6% | 3,199,087 | -2.4% | 0.15% | -3.2% |
Q3 2017 | $205,640,000 | +11.6% | 3,277,451 | +7.6% | 0.16% | +4.0% |
Q2 2017 | $184,321,000 | +19.3% | 3,044,713 | +2.2% | 0.15% | +13.7% |
Q1 2017 | $154,518,000 | +26.0% | 2,979,527 | +7.7% | 0.13% | +14.9% |
Q4 2016 | $122,649,000 | -14.6% | 2,766,170 | -8.3% | 0.11% | -21.9% |
Q3 2016 | $143,642,000 | +9.6% | 3,018,170 | +4.1% | 0.15% | +5.8% |
Q2 2016 | $131,045,000 | +11.6% | 2,898,355 | +1.4% | 0.14% | +6.2% |
Q1 2016 | $117,428,000 | +11.3% | 2,858,507 | +3.3% | 0.13% | +9.2% |
Q4 2015 | $105,540,000 | +23.8% | 2,766,686 | +6.6% | 0.12% | +14.4% |
Q3 2015 | $85,259,000 | -51.7% | 2,595,135 | +2.9% | 0.10% | -49.8% |
Q2 2015 | $176,472,000 | +11.6% | 2,522,847 | +9.3% | 0.21% | +9.5% |
Q1 2015 | $158,161,000 | -5.9% | 2,308,885 | +0.7% | 0.19% | -4.5% |
Q4 2014 | $168,162,000 | +1.3% | 2,293,832 | -0.8% | 0.20% | -0.5% |
Q3 2014 | $166,006,000 | -13.0% | 2,313,088 | -12.3% | 0.20% | -10.4% |
Q2 2014 | $190,720,000 | +1.2% | 2,636,310 | +2.9% | 0.22% | -3.1% |
Q1 2014 | $188,430,000 | -1.1% | 2,563,043 | -6.5% | 0.23% | -0.9% |
Q4 2013 | $190,488,000 | +8.5% | 2,740,151 | +2.6% | 0.23% | 0.0% |
Q3 2013 | $175,494,000 | -3.8% | 2,669,564 | +1.4% | 0.23% | -8.3% |
Q2 2013 | $182,477,000 | – | 2,633,469 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |